COVID-19. COVID-19
Conditions
Interventions
Patients in the two intervention and control groups, in addition to treatment according to the protocol, will rub the ointment and placebo 2 and 1 times five times a day for four hours in the amount o
Sponsors
Social Development and Health Promotion Research Center
Eligibility
Sex/Gender
All
Age
15 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients referred to a specialist center diagnosed by a suspected infectious disease specialist in Corona Have at least three symptoms of fever / chills, clear chest or voice / shortness of breath, cough / sore throat, general weakness / muscle pain, and have a positive CRP blood test and leukopenia.
Exclusion criteria
Exclusion criteria: . Pregnant and lactating mothers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fever. Timepoint: At the beginning of the study (before the start of the intervention) and 7 and 14 days after the start of intervention. Method of measurement: check list.;Chills. Timepoint: At the beginning of the study (before the start of the intervention) and 7 and 14 days after the start of intervention. Method of measurement: check list.;Respiratory rate. Timepoint: At the beginning of the study (before the start of the intervention) and 7 and 14 days after the start of intervention. Method of measurement: check list.;Inpatient period. Timepoint: At the beginning of the study (before the intervention) and 7 and 14 days after the intervention. Method of measurement: check list.;Death of patients. Timepoint: At the beginning of the study (before the intervention) and 7 and 14 days after the intervention. Method of measurement: check list. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHossein Mohammadzadeh- Moghadam
Gonabad University of Medical Sciences
Outcome results
None listed